Harokopio University
Διερεύνηση του μηχανισμού δράσης φυσικού και εδώδιμου προϊόντος στην παθοφυσιολογία του καρκίνου του προστάτη: μελέτη μονοχορήγησης και συγχορήγησης με χημειοθεραπευτικό φάρμακο
Abstract
dc:descriptionIntroduction: Prostate cancer (PCa) is the second most common cancer and the sixth most common cause of death from cancer in men, being a major public health concern. Adriamycin (ADR) is an anthracycline widely used as a chemotherapeutical agent against a variety of cancers, including prostate cancer. However, Adriamycin causes severe cardiotoxic and nephrotoxic side effects to the patients, shown even after decades. Hence, there is an urgent need to discover new supplementary treatments in order to reduce ADR cytotoxicity in normal cells without affecting and even enhancing its antitumor potential. Over the last years, several natural dietary compounds have been tested for their anticancer activity, either alone or in combination with chemotherapeutical agents. Goal: Two natural extracts, SEE (Silymarin Enriched Extract) and GGE (Glycyrrhiza Glabra Extract), were isolated from the plant Silybum marianum (Asteraceae) and the plant Glycyrrhiza glabra (Fabaceae), respectively, in order to evaluate their effect on the proliferation of androgen-independent prostate cancer cells (PC-3), when they are administrated alone or in combination with Adriamycin. In addition, some aspects of the implicated mechanism of action of the two extracts were investigated, focusing on autophagy. Autophagy is an endogenous mechanism of cells delivering their own cytoplasmic materials and organelles to lysosomes for degradation and the role of autophagy in growth progression or prevention of cancer cells still remains controversial. Methodology: PC-3 cells were treated with SEE or GGE alone, with silibinin or silycristine (major bioactive compounds of SEE extract) alone and in combination with Adriamycin (ADR) and cell proliferation inhibition was evaluated by the MTT assay. Cell cycle alterations, apoptosis and autophagy rates were measured through flow cytometry while expression levels of autophagy related genes and proteins were evaluated by Real Time PCR, specific ELISA kits and western blotting. TEM (Transmission Electron Microscopy) was used to reveal ultrastructural features of autophagy while NMR spectrometry was used in order to determine the metabolic profile of cells after each treatment. Results: Treatment of PC3 cells with ADR, SEE, silibin and silychristine inhibited cell proliferation in a dose-dependent manner, with silibinin being more bioactive than silychristine. Moreover, silibin antiproliferative effect is comparable to SEE, suggesting that the overall effect of SEE extract is mainly attributed to silibin. Furthermore, SEE extract and its bioactive compounds exert an additive effect when combined with ADR, reducing the pharmacologically efficient dosage of ADR. In particular, the combinational scheme of ADR+SEE enhances the ADR induced protective autophagy in its initiative steps, yet it finally suppresses the autophagolysosome degradation, leading to an excessive cell death through the induction of apoptosis. GGE alone also has antiproliferative properties against PC-3 cells. GGE in co-treatment with ADR shows and additive effect, also reducing the pharmacologically efficient dosage of ADR. ADR+GGE co-treatment enhances both the autophagic and apoptotic machinery of PC-3 cells, leading to excessive cell death. In conclusion, both natural extracts tested (SEE and GGE) highly sensitize ADR-mediated cytotoxicity in PC-3 cells, suggesting the possibility of decreasing the ADR dosage, in order to reduce the side effects without reducing the pharmacological potential.
Degree
thesis:*- Grantor dc:publisher
- Harokopio University
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gioti, Aikaterini
- Γιώτη, Αικατερίνη
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46796